Venture Capital Blog

Investing can feel like a maze sometimes. You might wonder where to find opportunities with real growth potential. 

The impact of venture capital on healthcare innovation is clear. VC-backed companies have pioneered healthcare innovations in the past decade and are revolutionizing healthcare with new cancer and rare disease treatments, medical device innovations, and digital health.

Progentos Therapeutics announced that it has successfully raised $65 million in a Series A funding round. Progentos is a Boston-based startup with the mission of developing groundbreaking treatments for diseases that affect nerve cells, such as Multiple Sclerosis (MS) and other demyelinating diseases.

InStride Health, a pioneering provider of pediatric anxiety and Obsessive Compulsive Disorder (OCD) treatments, has secured a monumental $30M in Series B funding. Under CEO John Voith's leadership, this Boston-based organization is setting new standards in mental health care for adolescents.

Adsilico, a groundbreaking venture from the University of Leeds, has secured a £3.5 million seed investment towards transforming medical device testing. This infusion of funds, comprising £2 million from Northern Gritstone and £1.5 million from Parkwalk Advisors, marks a pivotal moment for the startup.